American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 278-283.e1 , 1 February 2010

Staphylococcus aureus Endophthalmitis: Antibiotic Susceptibilities, Methicillin Resistance, and Clinical Outcomes

  • James C. Major Jr

      Affiliations

    • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Michael Engelbert

      Affiliations

    • Department of Ophthalmology, Edward S. Harkness Eye Institute, College of Physicians and Surgeons, Columbia University, New York, New York
    • ,
  • Harry W. Flynn Jr

      Affiliations

    • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • Corresponding Author InformationInquiries to Harry W. Flynn, Jr, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL 33136
    • ,
  • Darlene Miller

      Affiliations

    • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • William E. Smiddy

      Affiliations

    • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    • ,
  • Janet L. Davis

      Affiliations

    • Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida

,Accepted 19 August 2009.

References 

  1. Flynn HW, Scott IU, Brod RD, Han DP. Current management of endophthalmitis. Int Ophthalmol Clin. 2004;44:115–137
  2. The Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122:830–846
  3. Lalwani GA, Flynn HWJ, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996–2005) (Clinical features, causative organisms, and visual acuity outcomes). Ophthalmology. 2008;115:473–476
  4. Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111–124
  5. Lindsay JA, Holden MT. Staphylococcus aureus: superbug, super genome?. Trends Microbiol. 2004;12:378–385
  6. Chambers HF. Community-associated MRSA—resistance and virulence converge. N Engl J Med. 2005;352:1485–1487
  7. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet. 2006;367:731–739
  8. Marangon FB, Miller D, Muallem MS, Romano AC, Alfonso EC. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol. 2004;137:453–458
  9. Ta CN, He L, Nguyen E, De Kaspar HM. Prospective randomized study determining whether a 3-day application of ofloxacin results in the selection of fluoroquinolone-resistant coagulase-negative Staphylococcus. Eur J Ophthalmol. 2006;16:359–364
  10. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40:100–107
  11. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005;115:642–648
  12. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–1453
  13. Blomquist PH. Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:322–345
  14. Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. 2007;144:313–315
  15. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1–17
  16. Mao LK, Flynn HW, Miller D, Pflugfelder SC. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol. 1993;116:584–589
  17. Labit CM, Claeys GW, Verbraeken HE, Verschraegen GL. Methicillin resistance of bacteria isolated from vitreous fluid from patients undergoing vitrectomy. Eur J Ophthalmol. 2001;11:160–165
  18. Masket S. Preventing, diagnosing, and treating endophthalmitis. J Cataract Refract Surg. 1998;24:725–726
  19. Schmitz S, Dick HB, Krummenauer F, Pfeiffer N. Endophthalmitis in cataract surgery: results of a German survey. Ophthalmology. 1999;106:1869–1877
  20. Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: do international comparisons help?. Lancet Infect Dis. 2001;1:251–261
  21. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–1771
  22. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol. 2006;124:479–483
  23. Deramo VA, Lai JC, Winokur J, Luchs J, Udell IJ. Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis. Am J Ophthalmol. 2008;145:413–417
  24. Hori Y, Nakazawa T, Maeda N, et al. Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones. J Cataract Refract Surg. 2009;35:475–479
  25. Gordon YJ. Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? (The heroes?). Am J Ophthalmol. 2001;131:371–376
  26. Harbarth S. Control of endemic methicillin-resistant Staphylococcus aureus: recent advances and future challenges. Clin Microbiol Infect. 2006;12:1154–1162
  27. Ness T, Schneider C. Endogenous endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA). Retina. 2009;29:831–834
  28. Pan ES, Diep BA, Charlebois ED, et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus—and their relation to community-associated disease activity. J Infect Dis. 2005;192:811–818

PII: S0002-9394(09)00626-6

doi: 10.1016/j.ajo.2009.08.023

American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 278-283.e1 , 1 February 2010

Article Tools

* Image Usage & Resolution